Abstract
Several studies have shown the beneficial effect of Cimetidine in gastroesophageal reflux disease (GERD) as regards the symptomatic, endoscopic, and to some extent also the histologic manifestations of this disease. Cimetidine up to a dose of 2 g daily has been used in the various trials reported [1–5].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bright-Asare P, El-Bassoussi M (1980) J Clin Gastroenterol 2:149–156
Noya G, Dettori G, Muscas AG, Delogu L, Niolu P, Marongui G, Spirito R, Biglioli P (1983) Min Med 74:783–786
Brown P (1979) Med J Aust 2:96–97
Fiasse R, Haning C, Lepot A, Desccamps C, Lamy F, Dive C (1980) Dig Dis Sci 25:750–755
Wesdorp E, Bartelsman J, Pape K, Dekker W, Tytgat GN (1978) Gastroenterology 74:821–824
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag
About this paper
Cite this paper
Kaul, B. et al. (1988). Cimetidine: A Gastroesophageal Reflux Antagonist?. In: Siewert, J.R., Hölscher, A.H. (eds) Diseases of the Esophagus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-86432-2_240
Download citation
DOI: https://doi.org/10.1007/978-3-642-86432-2_240
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-86434-6
Online ISBN: 978-3-642-86432-2
eBook Packages: Springer Book Archive